USPTO serial 88686161
IMPACT
Reviewed by CopyMark Law Group
Reg. 6183342Status 711
- Filing date
- Status date
- Registration date
- Oct 27, 2020
- Examiner
- JAGANNATHAN, SIDDHARTH
- Law office
- TMO LAW OFFICE 114
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IMPACT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
South San Francisco, CA
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cara R. Baer
Cara R. Baer BUTLER SNOW LLP6075 POPLAR AVE., SUITE 500MEMPHIS, TN 38119UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific analysis services, namely, neoepitope selection; neoepitope research, development and production of pharmaceuticals comprising personalized adoptive cell therapies; scientific analysis of neoepitopes; research, development and production of pharmaceuticals comprising the selection of and genetic encoding of neoepitopes; research, development and production of pharmaceuticals comprising adoptive cell therapies design of personalized adoptive cell therapies; medical analysis services, namely, detection of truncal cancer mutations in patient tumor cells; developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials involving neoepitopes; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific research advice regarding selection of a neoepitope for the design of a cell therapy and/or immunotherapy product | SECTION 7(e) - CANCELLED | May 1, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2023 | NCS7 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED | — |
| Nov 8, 2023 | C7.. | CANCELLED SECTION 7-TOTAL | — |
| Nov 7, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 7, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 16, 2023 | C7RF | REQUEST FOR SECT 7 TOTAL SURRENDER FILED | — |
| Jun 16, 2023 | ES7S | TEAS SECTION 7 SURRENDER RECEIVED | — |
| Oct 27, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 7, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 13, 2019 | NWAP | NEW APPLICATION ENTERED | — |